NCT07767136

Brief Summary

The goal of this randomized clinical trial was to examine whether adding structured self-talk to wearable-assisted walking could support physical activity and physical function in community-dwelling older adults. The study also examined whether wearable-assisted walking provided benefits compared with a walking program without wearable feedback. Participants were randomly assigned to one of three groups for 12 weeks: (1) wearable-assisted walking combined with structured self-talk, (2) wearable-assisted walking without structured self-talk, or (3) a walking-only active control condition. All groups followed the same moderate-intensity walking schedule. The main questions were whether wearable-assisted walking was associated with better physical activity and functional performance than walking alone, and whether adding structured self-talk provided additional benefits beyond wearable-assisted walking. Physical activity, functional performance, and other protocol-specified health-related measures were assessed before and after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 11, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 17, 2026

Completed
Last Updated

August 17, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

August 11, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

Structured Self-TalkWearable TechnologyWalking ExerciseCommunity-Dwelling Older AdultsPhysical ActivityFunctional PerformanceMuscle StrengthBody Composition

Outcome Measures

Primary Outcomes (6)

  • Change in Time Spent in Moderate-to-Vigorous Physical Activity

    Time spent in moderate-to-vigorous physical activity was assessed using a research-grade ActiGraph triaxial accelerometer during 7-day monitoring periods at baseline and after the 12-week intervention.

    Baseline and 12 weeks

  • Average Daily Step Count

    Average daily step count was measured using a research-grade ActiGraph triaxial accelerometer worn on the non-dominant wrist. Daily steps were summarized across valid monitoring days at baseline and after the 12-week intervention. Higher values indicate greater daily physical activity.

    Baseline and 12 weeks

  • Five-Times Sit-to-Stand

    Lower-extremity functional performance was assessed using the five-times sit-to-stand test. Completion time was recorded in seconds, with shorter times indicating better performance.

    Baseline and 12 weeks

  • Handgrip Strength

    Upper-extremity muscle strength was assessed using dominant-hand grip strength. Strength was recorded in kilograms, with higher values indicating greater grip strength.

    Baseline and 12 weeks

  • Timed Up and Go

    Dynamic balance and mobility were assessed using the Timed Up and Go test. Completion time was recorded in seconds, with shorter times indicating better performance.

    Baseline and 12 weeks

  • Appendicular Skeletal Muscle Mass Index

    Appendicular skeletal muscle mass index (ASMI) was assessed using an InBody 370S bioelectrical impedance analyzer and calculated as appendicular skeletal muscle mass divided by height squared (kg/m²). Higher values indicate greater appendicular muscle mass relative to height.

    Baseline and 12 weeks

Secondary Outcomes (2)

  • Exercise Self-Efficacy

    Baseline and 12 weeks

  • Exercise Motivation / Behavioral Regulation

    Baseline and 12 weeks

Study Arms (3)

Integrated Intervention Group

EXPERIMENTAL

Participants received a 12-week moderate-intensity walking program combined with wearable-based activity feedback and structured self-talk training. Walking was prescribed three times per week for 30 minutes per session at a rating of perceived exertion of 11-13. The wearable device provided real-time step feedback and haptic alerts. Structured self-talk training was provided weekly and progressed through awareness, acquisition, regulation, and maintenance stages.

Behavioral: Moderate-Intensity Walking ProgramDevice: Wearable Activity DeviceBehavioral: Structured Self-Talk Training

Technology-Assisted Group

ACTIVE COMPARATOR

Participants received the same 12-week moderate-intensity walking program and used the same wearable device for real-time activity feedback but did not receive structured self-talk training. Brief weekly contacts were limited to device operation, battery status, and wearing compliance and did not include psychological strategy training.

Behavioral: Moderate-Intensity Walking ProgramDevice: Wearable Activity Device

Active Control Group

ACTIVE COMPARATOR

Participants received the same 12-week moderate-intensity walking program without wearable-based activity feedback or structured self-talk training. Participants recorded the date, duration, and rating of perceived exertion of each walking session using a paper-based exercise log.

Behavioral: Moderate-Intensity Walking Program

Interventions

Participants performed moderate-intensity walking three times per week for 30 minutes per session over 12 weeks. Exercise intensity was prescribed at a rating of perceived exertion (RPE) of 11-13. This standardized walking program was provided to participants in all three study groups.

Active Control GroupIntegrated Intervention GroupTechnology-Assisted Group

A wrist-worn wearable activity device was used to provide real-time step feedback and haptic vibration alerts during the 12-week walking intervention. The device was used as a behavioral feedback tool to support walking participation. Data from the intervention wearable device were not used as the research outcome measure.

Integrated Intervention GroupTechnology-Assisted Group

Participants received weekly structured self-talk training throughout the 12-week intervention. The training was delivered by trained instructors and progressed through four stages: awareness, acquisition, regulation, and maintenance. Participants were taught to use structured motivational and instructional self-talk during walking and in response to wearable-generated feedback. Standardized scripts and fidelity checklists were used to support consistent intervention delivery.

Integrated Intervention Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Aged 65 years or older. Community-dwelling and independent in activities of daily living. Able to ambulate safely without physical assistance; use of a cane was permitted.
  • Cleared for participation in moderate-intensity physical activity using the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+).
  • Montreal Cognitive Assessment (MoCA) score of 24 or higher. Sufficient literacy and communication ability in Chinese to understand study instructions and complete study procedures.
  • Access to a smartphone and an internet connection. Able to independently perform basic smartphone and wearable-device operations, including charging the wearable device.
  • Willing to wear the study wearable device and comply with the intervention procedures.

You may not qualify if:

  • A medically treated fall within the previous 3 months. A major cardiovascular event within the previous 6 months. Lower-extremity surgery within the previous 6 months. Severe neuromuscular disease that could interfere with safe participation or outcome assessment.
  • Severe visual or auditory impairment that could interfere with communication or study assessments.
  • Use of medications known to substantially affect cognitive function or muscle performance.
  • Concurrent participation in another structured exercise or rehabilitation program.
  • A medical contraindication to moderate-intensity exercise, including unstable chronic medical conditions as determined by a healthcare professional.
  • Severe psychiatric disorder or cognitive impairment that could interfere with adherence to study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Senior Community Activity Center

Taipei, 臺灣省, 244, Taiwan

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • CHENG-EN WU, phd

    National Taiwan College of Performing Arts

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 17, 2026

Study Start

March 15, 2026

Primary Completion

June 30, 2026

Study Completion

June 30, 2026

Last Updated

August 17, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made publicly available because the informed consent obtained for this study did not include unrestricted public sharing of individual-level participant data. De-identified aggregate data may be provided upon reasonable request, subject to applicable ethical and institutional requirements.

Locations